Christine Beeton

6.9k total citations
84 papers, 4.2k citations indexed

About

Christine Beeton is a scholar working on Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Christine Beeton has authored 84 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 28 papers in Immunology and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Christine Beeton's work include Ion channel regulation and function (40 papers), Nicotinic Acetylcholine Receptors Study (17 papers) and T-cell and B-cell Immunology (14 papers). Christine Beeton is often cited by papers focused on Ion channel regulation and function (40 papers), Nicotinic Acetylcholine Receptors Study (17 papers) and T-cell and B-cell Immunology (14 papers). Christine Beeton collaborates with scholars based in United States, Australia and France. Christine Beeton's co-authors include K. George Chandy, Michael W. Pennington, Heike Wulff, Michael D. Cahalan, Peter A. Calabresi, George A. Gutman, Raymond S. Norton, Xueyou Hu, Rajeev B. Tajhya and Rameeza Allie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Christine Beeton

82 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine Beeton United States	34	3.0k	913	688	683	568	84	4.2k
Bernd Nürnberg Germany	48	4.3k 1.4×	991 1.1×	544 0.8×	337 0.5×	934 1.6×	153	6.6k
Marjan Huizing United States	46	3.1k 1.0×	896 1.0×	336 0.5×	628 0.9×	248 0.4×	160	6.6k
K. George Chandy United States	25	1.7k 0.6×	456 0.5×	558 0.8×	304 0.4×	647 1.1×	67	2.6k
Rainer Schreiber Germany	57	5.8k 1.9×	404 0.4×	990 1.4×	562 0.8×	1.3k 2.3×	188	8.2k
Michael Nehls Germany	29	2.9k 1.0×	1.1k 1.2×	314 0.5×	560 0.8×	501 0.9×	53	5.1k
Futoshi Shibasaki Japan	39	4.4k 1.5×	719 0.8×	579 0.8×	281 0.4×	703 1.2×	96	6.1k
James I. Healy United States	13	2.3k 0.8×	1.8k 1.9×	247 0.4×	268 0.4×	562 1.0×	15	4.4k
Françoise Cluzeaud France	38	3.0k 1.0×	271 0.3×	266 0.4×	407 0.6×	732 1.3×	71	4.5k
Susan Treves Switzerland	40	3.4k 1.1×	415 0.5×	1.5k 2.2×	243 0.4×	1.0k 1.8×	150	4.6k
Andrew J. H. Smith United Kingdom	33	3.4k 1.1×	726 0.8×	201 0.3×	706 1.0×	701 1.2×	57	5.7k

Countries citing papers authored by Christine Beeton

Since Specialization

Citations

This map shows the geographic impact of Christine Beeton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Beeton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Beeton more than expected).

Fields of papers citing papers by Christine Beeton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Beeton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Beeton. The network helps show where Christine Beeton may publish in the future.

Co-authorship network of co-authors of Christine Beeton

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Beeton. A scholar is included among the top collaborators of Christine Beeton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Beeton. Christine Beeton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Duolong, Jacob L. Perry, Michael W. Pennington, et al.. (2023). A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis. Proceedings of the National Academy of Sciences. 120(2). e2211977120–e2211977120. 20 indexed citations

Hurley, Ayrea, Marco De Giorgi, Mark R. Tanner, et al.. (2023). Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver. PLoS ONE. 18(4). e0283996–e0283996. 1 indexed citations

Tanner, Mark R., Michael W. Pennington, Satendra Chauhan, et al.. (2019). KCa1.1 and Kv1.3 channels regulate the interactions between fibroblast-like synoviocytes and T lymphocytes during rheumatoid arthritis. Arthritis Research & Therapy. 21(1). 6–6. 16 indexed citations

Lee, Chang Seok, Adán Dagnino-Acosta, Viktor Yarotskyy, et al.. (2015). Ca2+ permeation and/or binding to CaV1.1 fine-tunes skeletal muscle Ca2+ signaling to sustain muscle function. Skeletal Muscle. 5(1). 4–4. 38 indexed citations

Laragione, Teresina, Kai Cheng, Mark R. Tanner, et al.. (2015). The cation channel Trpv2 is a new suppressor of arthritis severity, joint damage, and synovial fibroblast invasion. Clinical Immunology. 158(2). 183–192. 38 indexed citations

Ayyar, B. Vijayalakshmi, Rajeev B. Tajhya, Christine Beeton, & M. Zouhair Atassi. (2015). Antigenic sites on the HN domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin. Scientific Reports. 5(1). 15776–15776. 13 indexed citations

Koshy, Shyny, Redwan Huq, Mark R. Tanner, et al.. (2014). Blocking KV1.3 Channels Inhibits Th2 Lymphocyte Function and Treats a Rat Model of Asthma. Journal of Biological Chemistry. 289(18). 12623–12632. 53 indexed citations

Tajhya, Rajeev B., Xueyou Hu, Mark R. Tanner, Lubov Timchenko, & Christine Beeton. (2014). The Functional Swtich in Potassium Channels in Myotonic Dystrophy Type 1 Impairs Proliferation, Migration and Fusion During Myogenesis. Biophysical Journal. 106(2). 551a–551a.

Huq, Redwan, Mark R. Tanner, Sandeep Chhabra, et al.. (2014). A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases. Scientific Reports. 4(1). 4509–4509. 70 indexed citations

10.

Koshy, Shyny, Danli Wu, Xueyou Hu, et al.. (2013). Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes. PLoS ONE. 8(10). e76740–e76740. 43 indexed citations

11.

Tarcha, Eric J., Luz M. Londono, Amy Banks, et al.. (2012). Durable pharmacological responses from the peptide drug ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease (51.5). The Journal of Immunology. 188(1_Supplement). 51.5–51.5. 1 indexed citations

12.

Chi, Victor, Michael W. Pennington, Raymond S. Norton, et al.. (2011). Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases. Toxicon. 59(4). 529–546. 171 indexed citations

13.

Hu, Xueyou & Christine Beeton. (2010). Detection of Functional Matrix Metalloproteinases by Zymography. Journal of Visualized Experiments. 108 indexed citations

14.

Hu, Xueyou & Christine Beeton. (2010). Detection of Functional Matrix Metalloproteinases by Zymography. Journal of Visualized Experiments. 30 indexed citations

15.

Beeton, Christine, et al.. (2007). Enrichment of NK Cells from Human Blood with the RosetteSep Kit from StemCell Technologies. Journal of Visualized Experiments. 326–326. 6 indexed citations

16.

Beeton, Christine, Michael W. Pennington, Heike Wulff, et al.. (2005). Targeting Effector Memory T Cells with a Selective Peptide Inhibitor of Kv1.3 Channels for Therapy of Autoimmune Diseases. Molecular Pharmacology. 67(4). 1369–1381. 212 indexed citations

17.

Devaux, Jérôme, Christine Beeton, Evelyne Béraud, & Marcel Crest. (2004). Canaux ioniques et démyélinisation : les fondements d’un traitement de l’encéphalomyélite autoimmune expérimentale (EAE) par des bloqueurs des canaux potassium. Revue Neurologique. 160(5). 16–27. 12 indexed citations

18.

Wulff, Heike, Peter A. Calabresi, Rameeza Allie, et al.. (2003). The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS. Journal of Clinical Investigation. 111(11). 1703–1713. 359 indexed citations

19.

Beeton, Christine, Jocelyne Barbaria, Pierre Giraud, et al.. (2001). Selective Blocking of Voltage-Gated K+ Channels Improves Experimental Autoimmune Encephalomyelitis and Inhibits T Cell Activation. The Journal of Immunology. 166(2). 936–944. 166 indexed citations

20.

Bray, R. J., Christine Beeton, William Hinton, & John Seviour. (1986). Plasma morphine levels produced by continuous infusion in children. Anaesthesia. 41(7). 753–755. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact